Musculoskeletal Myeloid Sarcoma: Clinical, Imaging, Management, and Outcomes in 41 Adult Patients
Rajendra Kumar1, Sinchun Hwang2, Mathew Antony1
1Department of Diagnostic Imaging, The University of Texas M.D. Anderson Cancer Center, Houston, TX.
Musculoskeletal myeloid sarcoma is a rare complication of acute myeloid leukemia (AML). Imaging like MRI and PET-CT aids detection and monitoring, but outcomes remain poor with short survival.
Area of Science:
- Hematology
- Oncology
- Radiology
Background:
- Musculoskeletal myeloid sarcoma (MS) is a rare manifestation of myeloid malignancies.
- It can occur in patients with known leukemia or as an initial presentation.
Purpose of the Study:
- To analyze the clinical presentation, imaging characteristics, management strategies, and outcomes of musculoskeletal myeloid sarcoma in adult leukemia patients.
Main Methods:
- Retrospective analysis of 41 adult patients with biopsy-proven musculoskeletal myeloid sarcoma.
- Evaluation of clinical symptoms, imaging findings (MRI, PET-CT), treatment modalities, and survival data.
Main Results:
- Most patients had acute or chronic myeloid leukemia; some had isolated MS.
- Bone lesions were predominantly lytic; muscle tumors were often asymptomatic.
- Imaging features were nonspecific, but MRI and PET-CT were valuable for detection and monitoring.
- Mean survival after MS onset was 12.1 months for deceased patients.
Conclusions:
- Musculoskeletal myeloid sarcoma is a rare, often asymptomatic, complication of AML.
- Advanced imaging (MRI, PET-CT) is crucial for diagnosis and treatment surveillance.
- The disease carries a poor prognosis with limited survival.
More Related Videos
06:53Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Published on: September 9, 2020
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Tumor Immunotherapy
Cancer Survival Analysis
